Mieke Dewerchin
Center for Transgene Technology and Gene Therapy
Flanders Interuniversity Institute for Biotechnology
Leuven
Belgium
Name/email consistency: high
- Inhibition of factor VIII with a partially inhibitory human recombinant monoclonal antibody prevents thrombotic events in a transgenic model of type II HBS antithrombin deficiency in mice. Dewerchin, M., Van der Elst, L., Singh, I., Grailly, S., Saint-Remy, J.M., Collen, D., Jacquemin, M. J. Thromb. Haemost. (2004)
- Life-threatening thrombosis in mice with targeted Arg48-to-Cys mutation of the heparin-binding domain of antithrombin. Dewerchin, M., Hérault, J.P., Wallays, G., Petitou, M., Schaeffer, P., Millet, L., Weitz, J.I., Moons, L., Collen, D., Carmeliet, P., Herbert, J.M. Circ. Res. (2003)
- Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1. Dewerchin, M., Collen, D., Lijnen, H.R. Thromb. Haemost. (2001)